Pharmacodynamics of first-in-class p97 inhibitors that disrupt protein homeostasis in cancer

被引：1
|
作者：
Srivastava, Apurva K.
Govindharajulu, Jeevan P.
Hollingshead, Melinda G.
Stotler, Howard
Wang, Feng
Chou, Tsui-Fen
Banfield, Kelly
Tomaino, Francesca
Stott, Gordon
Doroshow, James H.
Parchment, Ralph E.
机构：
[1] Frederick Natl Labs Canc Res, Clin Pharmacodynam Biomarker Program, Frederick, MD USA
[2] NCI, Div Canc Treatment Diag, Frederick, MD USA
[3] Frederick Natl Lab Canc Res, Frederick, MD USA
[4] UCLA, David Geffen Sch Med, Los Angeles, CA USA
[5] Leidos Biomed Res, Frederick, MD USA
[6] Ctr Canc Res, Div Canc Treatment & Diag, Bethesda, MD USA
[7] 1050 Boyles St, Frederick, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e14539
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14539
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeting p97 to Disrupt Protein Homeostasis in Cancer
    Vekaria, Pratikkumar Harsukhbhai
    Home, Trisha
    Weir, Scott
    Schoenen, Frank J.
    Rao, Rekha
    FRONTIERS IN ONCOLOGY, 2016, 6
  • [2] CB-5083, a first-in-class p97 inhibitor that disrupts protein homeostasis, exhibits anti-tumor activity in a panel of solid tumor xenografts
    Lee, G. J.
    Le Moigne, R.
    Anderson, D. J.
    Djakovic, S.
    Menon, M. K.
    Valle, E.
    Wong, S.
    Soriano, F.
    Tang, Y.
    Yao, B.
    Zhou, H. J.
    Rajangam, K.
    Rolfe, M.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S151 - S152
  • [3] Discovery of a new class of valosine containing protein (VCP/P97) inhibitors for the treatment of colorectal cancer
    Wang, Xueyuan
    Wen, Tiantian
    Miao, Hang
    Hu, Wenjiao
    Lei, Meng
    Zhu, Yongqiang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 74
  • [4] VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy
    Lan, B.
    Chai, S.
    Wang, P.
    Wang, K.
    CURRENT MOLECULAR MEDICINE, 2017, 17 (09) : 608 - 618
  • [5] Characterization of mechanism of action and drug resistance of the first-in-class p97/VCP inhibitor CB-5083.
    Rice, J.
    Kumar, B.
    Djakovic, S.
    Madriaga, A.
    Wong, S.
    Valle, E.
    Soriano, F.
    Menon, M. K.
    Wang, J.
    Yao, B.
    LeMoigne, R.
    Zhou, H.
    Wustrow, D.
    Rolfe, M.
    Anderson, D. J.
    MOLECULAR BIOLOGY OF THE CELL, 2015, 26
  • [6] Targeting the AAA ATPase p97 as an Approach to Treat Cancer through Disruption of Protein Homeostasis
    Anderson, Daniel J.
    Le Moigne, Ronan
    Djakovic, Stevan
    Kumar, Brajesh
    Rice, Julie
    Wong, Steve
    Wang, Jinhai
    Yao, Bing
    Valle, Eduardo
    von Soly, Szerenke Kiss
    Madriaga, Antonett
    Soriano, Ferdie
    Menon, Mary-Kamala
    Wu, Zhi Yong
    Kampmann, Martin
    Chen, Yuwen
    Weissman, Jonathan S.
    Aftab, Blake T.
    Yakes, F. Michael
    Shawver, Laura
    Zhou, Han-Jie
    Wustrow, David
    Rolfe, Mark
    CANCER CELL, 2015, 28 (05) : 653 - 665
  • [7] The p97 inhibitor CB-5083 is a unique disrupter of protein homeostasis in cancer.
    Wu, Z.
    Djakovic, S.
    Rice, J.
    Kumar, B.
    von Soly, S. Kiss
    Madriaga, A.
    Valle, E.
    Soriano, F.
    Menon, M. K.
    Wang, J.
    Yao, B.
    Tang, Y.
    LeMoigne, R.
    Zhou, H.
    Wustrow, D.
    Rolfe, M.
    Anderson, D. J.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [8] Pre-Clinical Activity of the Novel, First-in-Class p97 Inhibitor, CB-5083, in Multiple Myeloma
    Aftab, Blake T.
    Anderson, Daniel J.
    Le Moigne, Ronan
    Djakovic, Stevan
    Dhimolea, Eugen
    Murnane, Megan
    King, Emily
    Rice, Julie
    Wong, Steve
    Kumar, Brajesh
    Valle, Eduardo
    Menon, Mary-Kamala
    von Soly, Szerenke Kiss
    Wang, Jinhai
    Yao, Bing
    Soriano, Ferdie
    Kampmann, Martin
    Alcost-Alvear, Diego
    Chesi, Marta
    Bergsagel, Leif
    Yakes, F. Michael
    Zhou, Han-Jie
    Wustrow, David
    Martin, Thomas G.
    Wolf, Jeffrey L.
    Mitsiades, Constantine S.
    Rolfe, Mark
    BLOOD, 2014, 124 (21)
  • [9] Discovery of a First-in-Class, Potent, Selective, and Orally Bioavailable Inhibitor of the p97 AAA ATPase (CB-5083)
    Zhou, Han-Jie
    Wang, Jinhai
    Yao, Bing
    Wong, Steve
    Djakovic, Stevan
    Kumar, Brajesh
    Rice, Julie
    Valle, Eduardo
    Soriano, Ferdie
    Menon, Mary-Kamala
    Madriaga, Antonett
    von Soly, Szerenke Kiss
    Kumar, Abhinav
    Parlati, Francesco
    Yakes, F. Michael
    Shawver, Laura
    Le Moigne, Ronan
    Anderson, Daniel J.
    Rolfe, Mark
    Wustrow, David
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (24) : 9480 - 9497
  • [10] Discovery of a first-in-class, potent, selective and orally bioavailable inhibitor of the p97 AAA ATPase (CB-5083)
    Zhou, Han-Jie
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
12345